Industry / Slovenia
Krka Enters Acquisition Market
November 2007 | Industry NewsSlovenian drugmaker Krka is to make its first venture into Western Europe with the planned acquisition for German generics firm TAD Pharma in a deal reported to be worth EUR97mn (US$142.48mn).
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
